Viewing nowCombinationAtorvastatin Calcium Trihydrate / Ezetimibe Tablets 10/20 mg
Atorvastatin Calcium Trihydrate 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
(Yuhan Corporation) Co., Ltd.

MFDS item code 202101382 · Approved 2021.02.18 · Insurance code 642105700
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication is used as an adjunct to diet to lower high cholesterol and various lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing good cholesterol (HDL). It is also used in patients with homozygous familial hypercholesterolemia either in combination with other lipid-lowering treatments or as an alternative when other treatments are ineffective. This medication helps regulate lipid levels in patients at high risk for vascular disease and is recommended when dietary and non-pharmacological treatments are insufficient. It is also important to identify and manage secondary causes such as diabetes and hypothyroidism before starting treatment. During the treatment process, total cholesterol, LDL, HDL, and triglyceride levels should be systematically checked, and appropriate adjustments should be made according to the patient’s health status. This medication is used effectively to improve such dyslipidemias.
Administer this medication once daily, with or without food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose of this medication should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. 1. Primary hypercholesterolemia The dosage range of this medication is 10/10mg∼10/80mg daily. The recommended initial dose is 10/10mg or 10/20mg daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg daily. After starting treatment with this medication or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. 2. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg daily. This medication is administered as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not suitable.
This medication is used to lower blood cholesterol levels. Symptoms such as muscle pain or weakness may occur while taking this medication, and if these symptoms are severe or accompanied by fever or malaise, immediate consultation with a physician is required. Serious muscle-related problems can also affect kidney function, so caution is necessary. Therefore, during acute infections, hypotension, after major surgeries, trauma, or severe metabolic disorders, this medication may be temporarily suspended. Individuals with impaired liver function or liver disease should not take this medication and regular liver function tests should be conducted before and during treatment. If this medication is taken in conjunction with certain drugs, the risk of muscle-related side effects may increase, so if other medications are being taken, consultation with a physician or pharmacist is mandatory. Pregnant women or women who could become pregnant, as well as breastfeeding women, should not take this medication, and women of childbearing age must use appropriate contraception while on this medication. Additionally, this medication has not been established as safe and effective for children, thus it is not recommended. Elderly individuals are at higher risk for myopathy, so caution is required during use, but no special dose adjustments are necessary. In the case of overdose, there are no specific antidotes, so treatment should be symptomatic, monitoring liver function and muscle condition. This medication should be stored out of the reach of children and transferring to other containers should be avoided. Caution is required when driving or operating machinery as dizziness may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at room temperature between 1 and 30 degrees Celsius.
White, biconvex, rectangular film-coated tablets
30 tablets/box [10 tablets/PTP x3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium Trihydrate 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
(Yuhan Corporation) Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.